Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1963 2
1964 4
1967 3
1969 1
1970 2
1971 1
1977 1
1978 1
1982 1
1983 3
1984 1
1988 5
1989 5
1990 1
1991 3
1992 2
1993 2
1994 4
1995 2
1996 4
1997 8
1998 7
1999 3
2000 7
2001 4
2002 3
2003 9
2004 1
2005 2
2006 1
2007 4
2008 9
2009 4
2010 8
2011 7
2012 2
2013 5
2014 4
2015 2
2016 4
2017 4
2018 5
2019 7
2020 8
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

159 results
Results by year
Filters applied: . Clear all
Page 1
Proinflammatory IgG Fc structures in patients with severe COVID-19.
Chakraborty S, Gonzalez J, Edwards K, Mallajosyula V, Buzzanco AS, Sherwood R, Buffone C, Kathale N, Providenza S, Xie MM, Andrews JR, Blish CA, Singh U, Dugan H, Wilson PC, Pham TD, Boyd SD, Nadeau KC, Pinsky BA, Zhang S, Memoli MJ, Taubenberger JK, Morales T, Schapiro JM, Tan GS, Jagannathan P, Wang TT. Chakraborty S, et al. Among authors: morales t. Nat Immunol. 2021 Jan;22(1):67-73. doi: 10.1038/s41590-020-00828-7. Epub 2020 Nov 9. Nat Immunol. 2021. PMID: 33169014 Free PMC article.
Chronic kidney disease and the olfactory system.
Robles-Osorio ML, Corona R, Morales T, Sabath E. Robles-Osorio ML, et al. Among authors: morales t. Nefrologia (Engl Ed). 2020 Mar-Apr;40(2):120-125. doi: 10.1016/j.nefro.2019.04.009. Epub 2019 Jul 29. Nefrologia (Engl Ed). 2020. PMID: 31371033 Free article. Review. English, Spanish.
Symptomatic SARS-CoV-2 infections display specific IgG Fc structures.
Chakraborty S, Edwards K, Buzzanco AS, Memoli MJ, Sherwood R, Mallajosyula V, Xie MM, Gonzalez J, Buffone C, Kathale N, Providenza S, Jagannathan P, Andrews JR, Blish CA, Krammer F, Dugan H, Wilson PC, Pham TD, Boyd SD, Zhang S, Taubenberger JK, Morales T, Schapiro JM, Parsonnet J, Wang TT. Chakraborty S, et al. Among authors: morales t. medRxiv. 2020 May 18:2020.05.15.20103341. doi: 10.1101/2020.05.15.20103341. Preprint. medRxiv. 2020. PMID: 32511463 Free PMC article. Updated.
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors.
Drilon A, Nagasubramanian R, Blake JF, Ku N, Tuch BB, Ebata K, Smith S, Lauriault V, Kolakowski GR, Brandhuber BJ, Larsen PD, Bouhana KS, Winski SL, Hamor R, Wu WI, Parker A, Morales TH, Sullivan FX, DeWolf WE, Wollenberg LA, Gordon PR, Douglas-Lindsay DN, Scaltriti M, Benayed R, Raj S, Hanusch B, Schram AM, Jonsson P, Berger MF, Hechtman JF, Taylor BS, Andrews S, Rothenberg SM, Hyman DM. Drilon A, et al. Among authors: morales th. Cancer Discov. 2017 Sep;7(9):963-972. doi: 10.1158/2159-8290.CD-17-0507. Epub 2017 Jun 3. Cancer Discov. 2017. PMID: 28578312 Free PMC article. Clinical Trial.
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Hatzivassiliou G, Song K, Yen I, Brandhuber BJ, Anderson DJ, Alvarado R, Ludlam MJ, Stokoe D, Gloor SL, Vigers G, Morales T, Aliagas I, Liu B, Sideris S, Hoeflich KP, Jaiswal BS, Seshagiri S, Koeppen H, Belvin M, Friedman LS, Malek S. Hatzivassiliou G, et al. Among authors: morales t. Nature. 2010 Mar 18;464(7287):431-5. doi: 10.1038/nature08833. Epub 2010 Feb 3. Nature. 2010. PMID: 20130576
159 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page